论文部分内容阅读
提要１７例折返性室上性心动过速（ＲＳＶＴ）口服莫雷西嗪６００ｍｇ／ｄ后，经食管心房调搏证实：该药对ＲＳＶＴ电诱发的总抑制率为８８．２％（１５／１７例）。１例出现致心律失常作用；非心源性副作用轻微，发生率低。结果提示，莫雷西嗪可试用于预防ＲＳＶＴ的发作。
Abstract 17 cases of reentrant supraventricular tachycardia (RSVT) were treated with esomeprazole 600 mg / d, and confirmed by transesophageal atrial pacing that the total inhibitory rate of this drug to RSVT was 88.2% (15/17 example). 1 case of arrhythmia; minor non-cardiac side effects, the incidence was low. The results suggest that Moreinezine can be used to prevent the onset of RSVT.